Cold-chain handling: what 2–8 °C really requires
Cold-chain is more than a fridge. A practical look at the controls that keep a 2–8 °C biologic viable from intake to delivery.
The 2–8 °C band looks like a simple number on a label, but maintaining it across a supply chain is anything but simple. A biologic can lose efficacy after a single extended excursion, which is why cold-chain handling is one of the most closely regulated areas of GDP.
What continuous monitoring actually means
Continuous means continuous: the temperature is logged throughout intake, storage, picking, packing, and outbound transit — not just at the bookends. When an excursion occurs, it is documented, assessed, and either released or quarantined depending on the validated tolerance for that specific product.
- Calibrated data loggers on storage areas and shipping containers
- Validated excursion tolerances per product family
- Root-cause review and corrective action after every deviation
- Annual requalification of warehousing and transport lanes
- Pre-conditioned packaging for every cold-chain consignment
The handover problem
Most cold-chain failures do not happen in the warehouse. They happen at handovers — between transport carrier and receiving dock, between courier and pharmacy fridge, between dispatch and intake systems that don't talk to each other. We treat every handover as a controlled event with a recorded temperature, a signed acceptance, and a defined window for response.
“A cold-chain product that arrives on time but unmonitored has not actually arrived. It has only travelled.”
Excursion tolerances are product-specific, not facility-wide
It is tempting to set a single excursion tolerance for the whole warehouse — say, no more than two hours above 8 °C — and apply it uniformly. That is not how the regulation works. Every product family has its own validated stability data, often different by manufacturer and presentation. A vaccine and a biologic injectable that share a fridge can have very different recovery windows. Our deviation log records the per-product tolerance, not just the excursion.
Why this matters for specialty medicines
Many of the specialty and orphan treatments we source are cold-chain. That makes the discipline especially important — one warm afternoon in the wrong truck is the kind of avoidable failure that the monitoring regime is designed to prevent.
How partners can help
Receiving partners contribute to the chain by accepting at the dock, checking the data logger before signing, and storing immediately. We supply the equipment and the documentation; the receiving side controls the last 30 minutes, which is the most common point of failure. The clearer the handover protocol on both sides, the smaller the residual risk.